<DOC>
	<DOCNO>NCT00080574</DOCNO>
	<brief_summary>This study examine whether levothyroxine ( Synthroid , synthetic thyroid hormone ) affect way body handle drug . If levothyroxine affect metabolism drug , dose medication may need increase enhance action decrease avoid adverse reaction . Patients 18 year age old thyroid cancer participate NIH protocol # 77-DK-0096 receive long-term suppression therapy levothyroxine may eligible study . This study thyroid cancer potential new drug treat . Thyroid cancer patient study treatment regimen provide opportunity study drug metabolism patient levothyroxine therapy . Participants come NIH Clinical Center two occasion : regularly take levothyroxine , medication preparation radioactive iodide diagnostic scan procedure outline . The time interval two clinic visit depend whether first visit patient medication . Participants ask fast overnight visit abstain certain food beverages 48 72 hour visit . At visit , patient undergo follow procedure : - Medication history , limited physical examination , blood draw laboratory test , include test look gene important eliminate medication body . - Insertion catheter ( thin plastic tube ) arm vein collect blood sample . - Shave skin biopsy ( optional ) explore protein skin metabolize transport drug affect thyroid hormone . For procedure , skin clean , numbed medicine , small sample top layer remove razor blade . The wound heal 2 3 day . - Medication dosing . Participants take follow substance mouth time : 1 ) 200 mg caffeine , compound commonly find chocolate , soda/pop , coffee , tea non-prescription product prevent sleep ; 2 ) 30 mg dextromethorphan , non-prescription cough suppressant ; 3 ) 40 mg omeprazole , prescription drug heartburn stomach ulcer ; 4 ) 8 mg midazolam , prescription drug use cause relaxation drowsiness ; 5 ) 120 mg fexofenadine , non-sedating prescription antihistamine use treat allergy . - Blood urine sampling . Fifteen blood sample 5 mL ( 1 teaspoon ) collect catheter urine collect next 24 hour determine happen test drug body . Participants may resume normal diet 4 hour take study medication .</brief_summary>
	<brief_title>The Effect Thyroid Hormone Drug Elimination Cancer Patients</brief_title>
	<detailed_description>Interaction thyroid hormone commonly prescribe drug well document , result augmentation attenuation action either compound . Phase I drug metabolism mediate mostly enzymes belong cytochrome p450 superfamily . Studies animal cell culture show thyroid hormone play important role constitutive expression p450 enzyme , thus potentially alter metabolism effect variety drug . P-glycoprotein express major organ associate drug absorption , distribution , elimination body ( e.g . intestine , kidney , liver , skin , blood-brain barrier ) . Expression intestinal P-glycoprotein human also appear influenced thyroid hormone . We intend study effect thyroid hormone activity CYP1A2 , CYP2C19 , CYP2D6 , CYP3A4 P-glycoprotein use five-drug cocktail ( caffeine , omeprazole , dextromethorphan , midazolam , fexofenadine ) administer patient thyroid cancer , thyroid hormone suppression therapy ( condition subclinical hyperthyroidism ) treatment ( condition hypothyroidism ) time routine radioactive iodine scan . Additionally perform two skin biopsy order ass pattern expression metabolic enzyme drug transport proteins thyroid hormone suppression therapy .</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Subject sign informed consent document ; 2 . Subject great equal 18 year age ; 3 . Subjects diagnose thyroid cancer participate protocol 77DK0096 ; 4 . Subjects receive THST levothyroxine ; 5 . Serum TSH le 0.4 mIU/L THST , 20 mIU/L THST . EXCLUSION CRITERIA : Subject pregnant , currently breastfeed , practice birth control hormonal contraceptive , hormone replacement therapy ( HRT ) . Subject smoker . Subject confound medical illness ( e ) judgement investigator would pose added risk subject ( e.g . severe respiratory disease ) . Subject history substance abuse within past 5 year drug alcohol use , may affect enzyme level function . Caffeine caffeinecontaining beverage chocolate bar consumption within 48 hour schedule caffeine administration CYP1A2 phenotyping ; schedule omeprazole administration within 14 day study ; schedule dextromethorphan administration within 30 day study ; schedule fexofenadine administration within 7 day study . AST ALT great equal 2 time upper normal reference limit . Concurrent administration know CYP and/or Pgp inducer ( barbiturate , phenytoin , carbamazepine , rifampicin ) inhibitor ( amiodarone , atorvastatin , chloroquine , cimetidine , cotrimoxazole , cyclosporine , diltazem , erythromycin , fluoxetine fluvoxamine , isoniazid , itrakonazole , ketokonazole , metronidazole , mexiletine , nefazadone , norfloxacin , verapamil ) use alternative/complementary therapy least 30 day prior study study . Nonherbal vitamin mineral preparation allow . Inability obtain venous access sample collection , basal hemoglobin equal less 10 g/dl . Patients receive schedule therapy alprazolam , triazolam , clonazepam , diazepam , lorazepam , oxazepam , temazepam chlorodiazepoxide , within 30 day study . Patients consume grapefruit product ( juice fresh fruit ) , apple orange juice within 72 hr study . History intolerance caffiene , omeprazole , dextromethorphan , midazolam fexofenadine . The presence persistent diarrhea malabsorption syndrome would interfere patient 's ability adequately absorb drug ; and/or Patients receive monoamine oxidase inhibitor ( MAOIs ) phenelzine , tranylcypromine , isocarboxazid . Patients history cheloid formation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Drug Metabolism</keyword>
	<keyword>Levothyroxine</keyword>
	<keyword>Hypothyroidism</keyword>
	<keyword>Hyperthyroidism</keyword>
	<keyword>Drug Interactions</keyword>
	<keyword>Cytochrome P450</keyword>
	<keyword>P-Glycoprotein</keyword>
	<keyword>Drug Transport Proteins</keyword>
	<keyword>Thyroid Hormone</keyword>
	<keyword>Thyroid Cancer</keyword>
</DOC>